BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18627662)

  • 1. Managing tuberculosis and HIV in sub-Sahara Africa.
    Lalloo UG; Pillay S
    Curr HIV/AIDS Rep; 2008 Aug; 5(3):132-9. PubMed ID: 18627662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in HIV-infected patients: a comprehensive review.
    Aaron L; Saadoun D; Calatroni I; Launay O; Mémain N; Vincent V; Marchal G; Dupont B; Bouchaud O; Valeyre D; Lortholary O
    Clin Microbiol Infect; 2004 May; 10(5):388-98. PubMed ID: 15113314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.
    Pepper DJ; Rebe K; Morroni C; Wilkinson RJ; Meintjes G
    PLoS One; 2009; 4(2):e4520. PubMed ID: 19229341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.
    Cohen T; Lipsitch M; Walensky RP; Murray M
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7042-7. PubMed ID: 16632605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric drug-resistant tuberculosis: a global perspective: a global perspective.
    Reubenson G
    Paediatr Drugs; 2011 Dec; 13(6):349-55. PubMed ID: 21999648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.
    Corbett EL; Marston B; Churchyard GJ; De Cock KM
    Lancet; 2006 Mar; 367(9514):926-37. PubMed ID: 16546541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report from the XVI International AIDS Conference. Extensively drug-resistant TB in HIV/TB-coinfected patients in rural South Africa.
    Friedland GH
    AIDS Clin Care; 2006 Nov; 18(11):102. PubMed ID: 17183748
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
    Chem ED; Van Hout MC; Hope V
    BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City.
    Murphy RA
    Clin Infect Dis; 2008 Jun; 46(11):1729-32. PubMed ID: 18426372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.
    Havlir DV; Getahun H; Sanne I; Nunn P
    JAMA; 2008 Jul; 300(4):423-30. PubMed ID: 18647985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
    Harries AD; Hargreaves NJ; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1109-15. PubMed ID: 11769768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
    Migliori GB; Dheda K; Centis R; Mwaba P; Bates M; O'Grady J; Hoelscher M; Zumla A
    Trop Med Int Health; 2010 Sep; 15(9):1052-66. PubMed ID: 20545927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TB and HIV: joint problems, joint solutions?
    Elzinga G; Nunn P
    Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
    [No Abstract]   [Full Text] [Related]  

  • 19. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
    Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
    AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.